Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors

NCT01151670 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Brain Neoplasms, Malignant
Brain Neoplasms, Benign
Malignant Meningioma
Glioblastoma Multiforme
Anaplastic Astrocytoma

Interventions

DRUG: pioglitazone
DRUG: Pioglitazone

Sponsor

Wake Forest University Health Sciences